Edit |   |
---|---|
Antigenic Specificity | Complement component 5 |
Clone | monoclonal |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | n/a |
Format | unconjugated |
Size | n/a |
Concentration | n/a |
Applications | FuncS, IF, Neut, ELISA, FC, IP, ICC, |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human C5 Recombinant Antibody (Pexelizumab). Recombinant humanized (from mouse) antibody expressed in CHO binding to human Complement component 5. Pexelizumab is a drug designed to reduce side effects of coronary artery bypass grafting and angioplasty, among other types of cardiac surgery. It is a single chain variable fragment of a monoclonal antibody targeted against component 5 of the complement system. |
Immunogen | The details of the immunogen for this antibody are not available. |
Other Names | Pexelizumab;h5G1.1-scFv;C5;complement component 5;complement C5;CPAMD4;anaphylatoxin C5a analog;C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4;FLJ17816;FLJ17822;MGC142298; |
Gene, Accession # | UniProt: P01031 |
Catalog # | TAB-901 |
Price | please inquire |
Order / More Info | Complement component 5 Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |